Advertisementspot_img
Saturday, December 14, 2024

Delivering Stories of Progress

Advertisementspot_img

Israel unveils preliminary result of EXO-CD24 for COVID-19 treatment

Latest article

Advertisement - PS02barkero developers premium website

THEPHILBIZNEWS Partner Hotels

Hotel Okura Manila
Hotel 101
The Manor at Camp John Hay
Novotel Manila
Taal Vista Hotel
Advertisement - PS02barkero developers premium website

Investigator-initiated study Prof. Nadir Arber, Tel Aviv Sourasky Medical Center

In photo, Professor Nadir Arber the Israeli inventor shows the drug against COVID-19 (Photo from Israel Embassy Manila)

The Israel Embassy Manila invited some media to the briefing and presentation of Prof. Nadir Arber and Dr. Shiran Shapira of Ichilov Hospital, which was entrusted with developing this unique treatment.

The EXO-CD24 is an innovative compound based on enriched CD24 exosomes and is inhaled directly into the lungs to eradicate the cytokine storm that results from the COVID-19 virus. The briefing will be on the record.

Prof. Nadir Arber is an expert in internal medicine and gastroenterology, and is the Director of the Integrated Cancer Prevention Center. He is one of the hospital’s most prominent doctors and researchers and was entrusted with developing the treatment.

Dr. Shiran Shapira is the Head of the Laboratory for Molecular Biology at the Center for Cancer Diagnosis and Prevention at Ichilov Hospital. Dr. Shiran Shapira directs Prof. Arber’s lab and has been leading research into the CD24 protein for over two decades.

Prof. Nadir Arber and Dr. Shiran Shapira of Ichilov Hospital presented a briefing on the topic of the new Israeli treatment for coronavirus. EXO-CD24 is an innovative compound based on enriched CD24 exosomes, and is inhaled directly into the lungs to eradicate the cytokine storm that results from the COVID-19 virus. 

Prof. Nadir Arber is an expert in internal medicine and gastroenterology, and is the Director of the Integrated Cancer Prevention Center. He is one of the hospital’s most prominent doctors and researchers and was entrusted with developing the treatment. 

Dr. Shiran Shapira is the Head of the Laboratory for Molecular Biology at the Center for Cancer Diagnosis and Prevention at Ichilov Hospital. Dr. Shiran Shapira directs Prof. Arber’s lab and has been leading research into the CD24 protein for over two decades.

The Zoom briefing was held on 17 February 2021 at 10PM PST.

Advertisement - PS04spot_img

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Advertisement - PS05spot_img
Advertisement - PS01spot_img

Must read

Advertisement - PS03spot_img